Hospital Universitario Araba-ko ikertzaileekin lankidetzan egindako argitalpenak (162)

2024

  1. A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 21

  2. Effects of SARS-COVID-19 lockdown on menstrual patterns: A transversal large sample survey

    Medicina Clinica

  3. Update in endometriosis work-up and treatment

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 51, Núm. 1

  4. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 40, Núm. 1, pp. 2301554

2023

  1. Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value

    Journal of neuropathology and experimental neurology, Vol. 82, Núm. 2, pp. 169-179

  2. New pathogenic variant in DLX5: New clues for a clinical spectrum from split-hand-foot malformation to fibular aplasia, tibial campomelia and oligosyndactyly

    Frontiers in Genetics, Vol. 14

  3. Pathophysiology of abnormal uterine bleeding

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 50, Núm. 1

  4. m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes

    Genes and Diseases, Vol. 10, Núm. 5, pp. 1751-1754

  5. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. In silico identification and in vitro expression analysis of breast cancer-related m6A-SNPs

    Epigenetics, Vol. 17, Núm. 13, pp. 2144-2156

  2. Aromatase inhibitors in the treatment of endometriosis-associated pelvic pain: A systematic review

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 49, Núm. 1

  3. Evolution of oestrogen in combined hormonal contraception: From ethinylestradiol to estetrol via estradiol

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 49, Núm. 3

  4. Familial endometrial adenocarcinoma: MSH6 variant of unknown significance in the presence of phenocopy, what should be done?

    Revista Espanola de Patologia, Vol. 55, pp. S16-S20

  5. Over-the-counter access to progestin-only pills. The vision of Spanish women

    Progresos de Obstetricia y Ginecologia, Vol. 65, Núm. 6, pp. 217-228

  6. The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain

    European Journal of Contraception and Reproductive Health Care, Vol. 27, Núm. 6, pp. 494-503

2021

  1. Combined hormonal contraception and COVID-19

    European Journal of Contraception and Reproductive Health Care, Vol. 26, Núm. 2, pp. 128-131

  2. Efficacy, safety and non-contraceptive benefits of the continuous or extended use of the contraceptive vaginal ring

    Clinica e Investigacion en Ginecologia y Obstetricia

  3. Impact of the Lockdown Due to COVID-19 Pandemic in the Use of Combined Hormonal Oral Contraception in Spain - Results of a National Survey: Encovid

    OPEN ACCESS JOURNAL OF CONTRACEPTION, Vol. 12, pp. 103-111

  4. Low-grade extrauterine endometrial stromal sarcoma of the peritoneum: A case report and literature review

    Revista Espanola de Patologia, Vol. 54, Núm. 3, pp. 201-205

  5. One-step nucleic acid amplification (Osna) of sentinel lymph node in early-stage endometrial cancer: Spanish multicenter study (endo-osna)

    Cancers, Vol. 13, Núm. 17